SEARCH BY
| Category | Company |
|---|---|
| Founded | 1993 |
| Sector | Life Science |
| Employees | 4,759 |
| Revenue | 797M EUR (2024) |
Evotec is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies. Evotec was founded in 1993 and is based in Hamburg, Germany.
| DEAL STATS | # |
|---|---|
| Overall | 11 of 15 |
| Sector: Life Science M&A | 10 of 14 |
| Type: Add-on Acquisition M&A Deals | 8 of 11 |
| Country: United Kingdom M&A | 2 of 3 |
| Year: 2016 M&A | 1 of 1 |
| Size (of disclosed) | 3 of 6 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-05-28 |
Euprotec
Manchester, United Kingdom Euprotec is a specialty and highly collaborative preclinical Contract Research Organisation (CRO) delivering a comprehensive portfolio of infectious disease biology services. |
Buy | £3M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-07-30 |
Aptuit
Greenwich, Connecticut, United States Aptuit LLC is a provider of integrated early discovery to mid-phase drug development services in the pharmaceutical industry including Drug Design & Discovery, API Development and Manufacture, Solid State Chemistry, CMC, Preclinical and IND enabling GLP/GMP programs. Fully integrated drug discovery & development services are available from our facilities in the UK, Italy, and Switzerland. |
Buy | $300M |
